-
5
-
-
67650223692
-
-
Harrison Narcotic Tax Act. Public Law No. 223, 63rd Cong., approved December 17, 1914.
-
Harrison Narcotic Tax Act. Public Law No. 223, 63rd Cong., approved December 17, 1914.
-
-
-
-
6
-
-
0020331581
-
The effect of codeine on involutional and senile depression
-
Varga E. The effect of codeine on involutional and senile depression. Ann N Y Acad Sci. 1982;398:103-5.
-
(1982)
Ann N Y Acad Sci
, vol.398
, pp. 103-105
-
-
Varga, E.1
-
7
-
-
84869347879
-
-
Kraepelin E. Einführung in die psychiatrische Klinik: zweiunddreissig Vorlesungen. Leipzig: J.A. Barth; 1905.
-
Kraepelin E. Einführung in die psychiatrische Klinik: zweiunddreissig Vorlesungen. Leipzig: J.A. Barth; 1905.
-
-
-
-
8
-
-
0017623919
-
Enkephaline may mediate euphoria and drive-reduction reward
-
Belluzzi J, Stein L. Enkephaline may mediate euphoria and drive-reduction reward. Nature. 1977;266(5602): 556-8.
-
(1977)
Nature
, vol.266
, Issue.5602
, pp. 556-558
-
-
Belluzzi, J.1
Stein, L.2
-
9
-
-
0033461157
-
The role of nucleus accumbens dopamine in motivated behavior: A unifying interpretation with special reference to reward-seeking
-
Ikemoto S, Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Rev. 1999;31(1):6-41.
-
(1999)
Brain Res Rev
, vol.31
, Issue.1
, pp. 6-41
-
-
Ikemoto, S.1
Panksepp, J.2
-
10
-
-
0025114350
-
Regionally selective increases in mu opioid receptor density in the brains of suicide victims
-
Gross-Isseroff R, Dillon K, Israeli M, Biegon A. Regionally selective increases in mu opioid receptor density in the brains of suicide victims. Brain Res. 1990;530(2): 312-6.
-
(1990)
Brain Res
, vol.530
, Issue.2
, pp. 312-316
-
-
Gross-Isseroff, R.1
Dillon, K.2
Israeli, M.3
Biegon, A.4
-
11
-
-
0019466618
-
Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers
-
Naber D, Pickar D, Post R, Van Kammen D, Waters R, Ballenger J, Goodwin F, Bunney W. Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers. Am J Psychiatry. 1981;138(11):1457-62.
-
(1981)
Am J Psychiatry
, vol.138
, Issue.11
, pp. 1457-1462
-
-
Naber, D.1
Pickar, D.2
Post, R.3
Van Kammen, D.4
Waters, R.5
Ballenger, J.6
Goodwin, F.7
Bunney, W.8
-
12
-
-
0004074875
-
-
Sweetmen SC, Blake PS, McGlashan JM, Neathercoat GC, Parsons AV, eds, 35th Edition. London: Pharmaceutical Press;
-
Sweetmen SC, Blake PS, McGlashan JM, Neathercoat GC, Parsons AV, eds. Martindale: The Complete Drug Reference. 35th Edition. London: Pharmaceutical Press; 2006.
-
(2006)
Martindale: The Complete Drug Reference
-
-
-
13
-
-
67650232613
-
Possible involvement of endorphin withdraw in postpartum depression
-
Halbreich M, Endicott J. Possible involvement of endorphin withdraw in postpartum depression. Medical Hypotheses. 1981;7:1054-8.
-
(1981)
Medical Hypotheses
, vol.7
, pp. 1054-1058
-
-
Halbreich, M.1
Endicott, J.2
-
14
-
-
0020331584
-
Possible antidepressive effects of opioids: Action of buprenorphine
-
Emrich H, Vogt P, Herz A. Possible antidepressive effects of opioids: Action of buprenorphine. Ann N Y Acad Sci. 1982;398:108-12.
-
(1982)
Ann N Y Acad Sci
, vol.398
, pp. 108-112
-
-
Emrich, H.1
Vogt, P.2
Herz, A.3
-
15
-
-
0028835493
-
Buprenorphine treatment of refractory depression
-
Bodkin J, Alexander M, Zornberg G, Lukas S, Cole J. Buprenorphine treatment of refractory depression. Jour of Clin Psychopharm. 1995;15(1):49-57.
-
(1995)
Jour of Clin Psychopharm
, vol.15
, Issue.1
, pp. 49-57
-
-
Bodkin, J.1
Alexander, M.2
Zornberg, G.3
Lukas, S.4
Cole, J.5
-
16
-
-
67650244750
-
Buprenorphine: Pilot trials in borderline patients and opiate dependence
-
Harris LB, ed, Washington, D.C, U.S. Government Printing Office;
-
Resnick R, Falk F. Buprenorphine: Pilot trials in borderline patients and opiate dependence. In: Harris LB, ed. NIDA Research Monograph: Problems of Drug Dependence. Washington, D.C.: U.S. Government Printing Office; 1987.
-
(1987)
NIDA Research Monograph: Problems of Drug Dependence
-
-
Resnick, R.1
Falk, F.2
-
17
-
-
0029954336
-
Buprenorphine for depression
-
Callawaye E. Buprenorphine for depression. Biological Psychiatry. 1996;39(12):989-90.
-
(1996)
Biological Psychiatry
, vol.39
, Issue.12
, pp. 989-990
-
-
Callawaye, E.1
-
19
-
-
0025280310
-
Depressive symptoms during buprenorphine treatment of opioid abusers
-
Kosten T, Morgan C, Kosten T. Depressive symptoms during buprenorphine treatment of opioid abusers. J Subst Abuse Treat. 1990;7(1):51-4.
-
(1990)
J Subst Abuse Treat
, vol.7
, Issue.1
, pp. 51-54
-
-
Kosten, T.1
Morgan, C.2
Kosten, T.3
-
20
-
-
33646230298
-
Effectiveness of buprenorphine in double diagnosed patients. Buprenorphine as a psychotropic drug
-
Maremmani I, Pacini M, Pani P. Effectiveness of buprenorphine in double diagnosed patients. Buprenorphine as a psychotropic drug. Heroin Add Rel Clin Probl. 2006;8(1):31-48.
-
(2006)
Heroin Add Rel Clin Probl
, vol.8
, Issue.1
, pp. 31-48
-
-
Maremmani, I.1
Pacini, M.2
Pani, P.3
-
21
-
-
10044295011
-
Depressive symptoms during buprenorphine vs. methadone maintenance: Findings from a randomised, controlled trial in opioid dependence
-
Dean A, Bell J, Christie M, Mattick R. Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence. Eur Psychiatry. 2004;19(8):510-3.
-
(2004)
Eur Psychiatry
, vol.19
, Issue.8
, pp. 510-513
-
-
Dean, A.1
Bell, J.2
Christie, M.3
Mattick, R.4
-
22
-
-
0036775966
-
A trial of fluoxetine in methadone maintenance patients with depression
-
Dean A, Bell J, Mascord D, Parker G, Macdonald C. A trial of fluoxetine in methadone maintenance patients with depression. J Aff Disord. 72:1;85-90.
-
J Aff Disord
, vol.72
, Issue.1
, pp. 85-90
-
-
Dean, A.1
Bell, J.2
Mascord, D.3
Parker, G.4
Macdonald, C.5
-
23
-
-
0035143553
-
Mood state and methadone plasma concentrations
-
Dyer K, White J, Foster D, Bochner F, Memelaou A, Somogyi A. Mood state and methadone plasma concentrations. J Clin Psychopharm. 2001;21(1):78-84.
-
(2001)
J Clin Psychopharm
, vol.21
, Issue.1
, pp. 78-84
-
-
Dyer, K.1
White, J.2
Foster, D.3
Bochner, F.4
Memelaou, A.5
Somogyi, A.6
-
25
-
-
0020084845
-
Possible antidepressant activity of methadone
-
De Montis, G, Devoto P, Tagliamonte A. Possible antidepressant activity of methadone. Euro J Pharm. 1892;79(1-2);145-6.
-
(1892)
Euro J Pharm
, vol.79
, Issue.1-2
, pp. 145-146
-
-
De Montis, G.1
Devoto, P.2
Tagliamonte, A.3
-
26
-
-
0032731312
-
PET imaging of serotonin 1A receptor binding in depression
-
Drevets W, Frank E, Price J, Kupfer D, Holt D, Greer P, Huang Y, Gautier C, Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry. 1999;46(10):1375-87.
-
(1999)
Biol Psychiatry
, vol.46
, Issue.10
, pp. 1375-1387
-
-
Drevets, W.1
Frank, E.2
Price, J.3
Kupfer, D.4
Holt, D.5
Greer, P.6
Huang, Y.7
Gautier, C.8
Mathis, C.9
-
27
-
-
2942529391
-
Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression
-
Rosa-Neto P, Diksic M, Okazawa H, Leyton M, Ghadirian N, Mzengeza S, Nakai A, Debonnel G, Blier P, Benkelfat C. Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch Gen Psychiatry. 2004;61(6):556-63.
-
(2004)
Arch Gen Psychiatry
, vol.61
, Issue.6
, pp. 556-563
-
-
Rosa-Neto, P.1
Diksic, M.2
Okazawa, H.3
Leyton, M.4
Ghadirian, N.5
Mzengeza, S.6
Nakai, A.7
Debonnel, G.8
Blier, P.9
Benkelfat, C.10
-
28
-
-
10744225212
-
Reduced serotonin type 1A receptor binding in panic disorder
-
Neumeister A, Bain E, Nugent A, Carson R, Bonne O, Luckenbaugh D, Eckelman W, Herscovitch P, Charney D, Drevets W. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci. 2004;24(3):589-91.
-
(2004)
J Neurosci
, vol.24
, Issue.3
, pp. 589-591
-
-
Neumeister, A.1
Bain, E.2
Nugent, A.3
Carson, R.4
Bonne, O.5
Luckenbaugh, D.6
Eckelman, W.7
Herscovitch, P.8
Charney, D.9
Drevets, W.10
-
29
-
-
0034595401
-
A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary
-
Williams J, Mulrow C, Chiquette E, Noel P, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med. 2000;132(9):743-56.
-
(2000)
Ann Intern Med
, vol.132
, Issue.9
, pp. 743-756
-
-
Williams, J.1
Mulrow, C.2
Chiquette, E.3
Noel, P.4
Aguilar, C.5
Cornell, J.6
-
30
-
-
0016051507
-
Methadone inhibition of 5-hydroxytryptamine uptake
-
Ciofalo F. Methadone inhibition of 5-hydroxytryptamine uptake. J Pharmacol Exp Ther. 1974;189(1):83-9.
-
(1974)
J Pharmacol Exp Ther
, vol.189
, Issue.1
, pp. 83-89
-
-
Ciofalo, F.1
-
31
-
-
26444511151
-
Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity
-
Gillman P. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005;95(4):434-41.
-
(2005)
Br J Anaesth
, vol.95
, Issue.4
, pp. 434-441
-
-
Gillman, P.1
-
32
-
-
4944234170
-
Dual diagnosis heroin addicts: The clinical and therapeutic aspects
-
Maremmani I, Matteo P, Lubrano S, Lovreded M, Perugi G. Dual diagnosis heroin addicts: the clinical and therapeutic aspects. Heroin Add Rel Clin Probl. 2003;5(2):7-98.
-
(2003)
Heroin Add Rel Clin Probl
, vol.5
, Issue.2
, pp. 7-98
-
-
Maremmani, I.1
Matteo, P.2
Lubrano, S.3
Lovreded, M.4
Perugi, G.5
-
33
-
-
0034058726
-
The Effect of sertraline on methadone plasma levels in methadone maintenance patients
-
Hamilton S, Nunes E, Janal M, Weber L. The Effect of sertraline on methadone plasma levels in methadone maintenance patients. Am J Addict. 2000;9:63-9.
-
(2000)
Am J Addict
, vol.9
, pp. 63-69
-
-
Hamilton, S.1
Nunes, E.2
Janal, M.3
Weber, L.4
-
34
-
-
0030890624
-
Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of enantiomers of methadone
-
Eap C, Gilles M, Powell K, Baumann P. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of enantiomers of methadone. J Clin Psychopath. 1997;17(2):113-7.
-
(1997)
J Clin Psychopath
, vol.17
, Issue.2
, pp. 113-117
-
-
Eap, C.1
Gilles, M.2
Powell, K.3
Baumann, P.4
-
35
-
-
0036213788
-
Paroxetine increases steady state concentrations of methadone
-
Berge S, von Bardeleben U, Ladewig D, Jaquet S, Cosendai L, Golay K, Kosel M, Baumann P, Eap C. Paroxetine increases steady state concentrations of methadone. J Clin Psychopharmacol. 2002;22(2):211-5.
-
(2002)
J Clin Psychopharmacol
, vol.22
, Issue.2
, pp. 211-215
-
-
Berge, S.1
von Bardeleben, U.2
Ladewig, D.3
Jaquet, S.4
Cosendai, L.5
Golay, K.6
Kosel, M.7
Baumann, P.8
Eap, C.9
-
36
-
-
0037266206
-
Escitalopram: A review of its use in the management of major depressive and anxiety disorders
-
Waugh J, Goa K. Escitalopram: a review of its use in the management of major depressive and anxiety disorders. CNS Drugs. 2003;17:343-62.
-
(2003)
CNS Drugs
, vol.17
, pp. 343-362
-
-
Waugh, J.1
Goa, K.2
-
37
-
-
33750727989
-
Elevated monoamine oxidase a levels in the brain: An explanation for the monoamine imbalance of major depression
-
Meyer JH, Ginovart N, Boovariwala A, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry. 2006;63(11):1209-16.
-
(2006)
Arch Gen Psychiatry
, vol.63
, Issue.11
, pp. 1209-1216
-
-
Meyer, J.H.1
Ginovart, N.2
Boovariwala, A.3
Boovariwala, A.4
Sagrati, S.5
Hussey, D.6
Garcia, A.7
Young, T.8
-
38
-
-
0018751458
-
Effect of narcotics on monoamine oxidase activity of mouse brain
-
VanderWende C, Spoerlein M. Effect of narcotics on monoamine oxidase activity of mouse brain. Res Chem Pathol Pharmacol. 1979;24(1):103-13.
-
(1979)
Res Chem Pathol Pharmacol
, vol.24
, Issue.1
, pp. 103-113
-
-
VanderWende, C.1
Spoerlein, M.2
-
39
-
-
0034940889
-
Inhibitory effects of ethaverine on monoamine oxidase activity in mouse brain
-
Lee S, Lee J, Cheong M, Kim H, Kim Y, Yun Y, Lee C, Lee M. Inhibitory effects of ethaverine on monoamine oxidase activity in mouse brain. Biol Pharm Bull. 2001;24(7):838-40.
-
(2001)
Biol Pharm Bull
, vol.24
, Issue.7
, pp. 838-840
-
-
Lee, S.1
Lee, J.2
Cheong, M.3
Kim, H.4
Kim, Y.5
Yun, Y.6
Lee, C.7
Lee, M.8
-
40
-
-
0015534675
-
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
-
Sachar E, Hellman L, Roffwarg H, Halpern F, Fukushima D, Gallagher T. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry. 1973;28(1):19-24.
-
(1973)
Arch Gen Psychiatry
, vol.28
, Issue.1
, pp. 19-24
-
-
Sachar, E.1
Hellman, L.2
Roffwarg, H.3
Halpern, F.4
Fukushima, D.5
Gallagher, T.6
-
41
-
-
0019230676
-
Supression of plasma cortisol in depressed patients by acute intravenous methadone infusion
-
Gold P, Extein I, Pickar D, Rebar R, Ross R, Goodwin F. Supression of plasma cortisol in depressed patients by acute intravenous methadone infusion. Am J Psychiatry. 1980;137(7):862-3.
-
(1980)
Am J Psychiatry
, vol.137
, Issue.7
, pp. 862-863
-
-
Gold, P.1
Extein, I.2
Pickar, D.3
Rebar, R.4
Ross, R.5
Goodwin, F.6
-
42
-
-
0020447707
-
The effect of methadone on the behavioral and neuroendocrine responses of manic patients
-
Judd L, Parker D, Janowsky D, Segal D, Risch S, Huey L. The effect of methadone on the behavioral and neuroendocrine responses of manic patients. Psychiatry Res. 1982;7(2):163-70.
-
(1982)
Psychiatry Res
, vol.7
, Issue.2
, pp. 163-170
-
-
Judd, L.1
Parker, D.2
Janowsky, D.3
Segal, D.4
Risch, S.5
Huey, L.6
-
45
-
-
1342331172
-
Functional inhibition by methadone of NMDA receptors
-
Callahan R, Au J, Liu C, Yost C. Functional inhibition by methadone of NMDA receptors. Anesth Analg. 2004;98(3):653-9.
-
(2004)
Anesth Analg
, vol.98
, Issue.3
, pp. 653-659
-
-
Callahan, R.1
Au, J.2
Liu, C.3
Yost, C.4
-
46
-
-
33746896935
-
A randomized trial of NMDA antagonist in major depression
-
Zarate C, Singh J, Carlson P, Brutsche N, Ameli R, Luckenbaugh D. A randomized trial of NMDA antagonist in major depression. Arch Gen Psychiatry. 2006;63(8):856-64.
-
(2006)
Arch Gen Psychiatry
, vol.63
, Issue.8
, pp. 856-864
-
-
Zarate, C.1
Singh, J.2
Carlson, P.3
Brutsche, N.4
Ameli, R.5
Luckenbaugh, D.6
-
47
-
-
0031050171
-
The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord
-
Gorman A, Elliott K, Inturrisi C. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett. 1997;223(1): 5-8.
-
(1997)
Neurosci Lett
, vol.223
, Issue.1
, pp. 5-8
-
-
Gorman, A.1
Elliott, K.2
Inturrisi, C.3
-
48
-
-
0033969685
-
Antidepressant effects of ketamine in depressed patients
-
Berman R, Cappiello A, Anand A, Oren D. Antidepressant effects of ketamine in depressed patients. Biol Psych. 2000;47(4):351-4.
-
(2000)
Biol Psych
, vol.47
, Issue.4
, pp. 351-354
-
-
Berman, R.1
Cappiello, A.2
Anand, A.3
Oren, D.4
-
49
-
-
0028905662
-
Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord
-
Ebert B, Andersen S, Krogsgaard P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett. 1995;187(3):165-8.
-
(1995)
Neurosci Lett
, vol.187
, Issue.3
, pp. 165-168
-
-
Ebert, B.1
Andersen, S.2
Krogsgaard, P.3
-
50
-
-
0032901785
-
Methadone blocks morphine tolerance and NMDA induced hyperalgesia
-
Davis A, Inturrisi C. Methadone blocks morphine tolerance and NMDA induced hyperalgesia. Pharmacol and Exper Therap. 1999;289(2):1048-53.
-
(1999)
Pharmacol and Exper Therap
, vol.289
, Issue.2
, pp. 1048-1053
-
-
Davis, A.1
Inturrisi, C.2
-
51
-
-
33645763132
-
Psychiatric severity and treatment response in methadone programs
-
Pani P, Trogu E, Carboni G, Palla P, Loi A. Psychiatric severity and treatment response in methadone programs. Heroin Add Rel Clin Probl. 2003;5(3):23-36.
-
(2003)
Heroin Add Rel Clin Probl
, vol.5
, Issue.3
, pp. 23-36
-
-
Pani, P.1
Trogu, E.2
Carboni, G.3
Palla, P.4
Loi, A.5
-
52
-
-
0027495173
-
Methadone doses and psychopathological symptons during methadone maintenance
-
Maremmani I, Zolesi O, Agueci T, Castrogiovanni P. Methadone doses and psychopathological symptons during methadone maintenance. J Psychoact Drug. 1993;25(3):253-6.
-
(1993)
J Psychoact Drug
, vol.25
, Issue.3
, pp. 253-256
-
-
Maremmani, I.1
Zolesi, O.2
Agueci, T.3
Castrogiovanni, P.4
-
53
-
-
0030724155
-
Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program
-
Pani P, Trogu E, Contu P, Agus A, Gessa G. Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug Alcohol Depend. 1997;48(2):119-26.
-
(1997)
Drug Alcohol Depend
, vol.48
, Issue.2
, pp. 119-126
-
-
Pani, P.1
Trogu, E.2
Contu, P.3
Agus, A.4
Gessa, G.5
-
54
-
-
21244460724
-
Behavioral assessment of temporal summation in the rat: Sensitivity to sex, opioids and modulation by NMDA receptor antagonists
-
Lomas L, Picker M, Behavioral assessment of temporal summation in the rat: sensitivity to sex, opioids and modulation by NMDA receptor antagonists. Psychopharmacology (Berl). 2005;180(1):84-94.
-
(2005)
Psychopharmacology (Berl)
, vol.180
, Issue.1
, pp. 84-94
-
-
Lomas, L.1
Picker, M.2
-
55
-
-
0035069188
-
Potential anxiolytic effects of MPEP
-
Tatarczynska E. Potential anxiolytic effects of MPEP. Br J Pharmacol. 2001;132(7):1423-30.
-
(2001)
Br J Pharmacol
, vol.132
, Issue.7
, pp. 1423-1430
-
-
Tatarczynska, E.1
-
56
-
-
21244501728
-
Lamotrignine has an anxiolytic-like profile in rats
-
Mirza N, Bright J, Stanhope K, Wyatt A, Harrington N. Lamotrignine has an anxiolytic-like profile in rats. Psychopharmacology. 2005;180(1):159-68.
-
(2005)
Psychopharmacology
, vol.180
, Issue.1
, pp. 159-168
-
-
Mirza, N.1
Bright, J.2
Stanhope, K.3
Wyatt, A.4
Harrington, N.5
-
58
-
-
0027296366
-
Glutamate, GABA, glycine and taurine modulate serotonin synthesis and release in rostral and caudal rhombencephalic raphe cells in primary cultures
-
Becqet D, Hery M, Francois A, Giraud P, Deprez P, Faudon M, Fache M, Hery F. Glutamate, GABA, glycine and taurine modulate serotonin synthesis and release in rostral and caudal rhombencephalic raphe cells in primary cultures. Neurochem Int. 1993;23(3):269-83.
-
(1993)
Neurochem Int
, vol.23
, Issue.3
, pp. 269-283
-
-
Becqet, D.1
Hery, M.2
Francois, A.3
Giraud, P.4
Deprez, P.5
Faudon, M.6
Fache, M.7
Hery, F.8
-
59
-
-
34047241652
-
Long-term pharmacological treatment of bipolar disorders
-
Rybakowski J. Long-term pharmacological treatment of bipolar disorders. Neuro Endocrinol Lett. 2007; 28(Suppl1):71-93.
-
(2007)
Neuro Endocrinol Lett
, vol.28
, Issue.SUPPL.1
, pp. 71-93
-
-
Rybakowski, J.1
-
60
-
-
0033843920
-
-
Rosenberg D, MacMaster F, Keshavan M, Fitzgerald K, Stewart C, Moore G. Decrease in Caudate Glutamate in OCD. J Am Acad Child Adol Psych. 2000;39(9):1096-103.
-
Rosenberg D, MacMaster F, Keshavan M, Fitzgerald K, Stewart C, Moore G. Decrease in Caudate Glutamate in OCD. J Am Acad Child Adol Psych. 2000;39(9):1096-103.
-
-
-
-
61
-
-
33646883912
-
Chronic treatment with antidepressants reverses NMDA mediated regulation of 5-HT in rat brain
-
Owen J, Whitton P. Chronic treatment with antidepressants reverses NMDA mediated regulation of 5-HT in rat brain. Brain Res Bull. 2006;70(1):62-7.
-
(2006)
Brain Res Bull
, vol.70
, Issue.1
, pp. 62-67
-
-
Owen, J.1
Whitton, P.2
-
62
-
-
33846266524
-
Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent
-
Feb;
-
Stachowicz K, Chojnacka E, Klak K, Pilc A. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent. Neuropharmacology. Feb;52(2):306-12.
-
Neuropharmacology
, vol.52
, Issue.2
, pp. 306-312
-
-
Stachowicz, K.1
Chojnacka, E.2
Klak, K.3
Pilc, A.4
-
63
-
-
0032960426
-
Rapid remission of OCD with tramadol hydrochloride
-
Goldsmith M, Shapira N, Keck P. Rapid remission of OCD with tramadol hydrochloride. Am J Psychiatry. 1999;156:660-1.
-
(1999)
Am J Psychiatry
, vol.156
, pp. 660-661
-
-
Goldsmith, M.1
Shapira, N.2
Keck, P.3
-
64
-
-
0031448045
-
Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder
-
Shapira N, Keck P, Golsdmith T, McConville B, Eis M, McElroy S. Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder. Depress Anxiety. 1997;6(4):170-3.
-
(1997)
Depress Anxiety
, vol.6
, Issue.4
, pp. 170-173
-
-
Shapira, N.1
Keck, P.2
Golsdmith, T.3
McConville, B.4
Eis, M.5
McElroy, S.6
-
66
-
-
18844455279
-
Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons
-
Zhu W, Pan Z. Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience. 2005;133(1):97-103.
-
(2005)
Neuroscience
, vol.133
, Issue.1
, pp. 97-103
-
-
Zhu, W.1
Pan, Z.2
-
67
-
-
0004235298
-
-
American Psychiatric Association, 4th Edition, Text Revision. Washington, D.C, Author;
-
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders., 4th Edition, Text Revision. Washington, D.C.: Author; 2000.
-
(2000)
Diagnostic and Statistical Manual of Mental Disorders
-
-
-
68
-
-
33645829087
-
Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel
-
Peles E, Schreiber S, Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend. 2006;82(3):211-7.
-
(2006)
Drug Alcohol Depend
, vol.82
, Issue.3
, pp. 211-217
-
-
Peles, E.1
Schreiber, S.2
Adelson, M.3
-
69
-
-
0031786293
-
Psychiatric comorbidity in methadone maintained patients
-
Mason B, Kocsis J, Melia D, Khuri E, Sweeney J, Wells A, Borg L, Millman R, Kreek M. Psychiatric comorbidity in methadone maintained patients. J Addic Diseas. 1998;17(3):75-89.
-
(1998)
J Addic Diseas
, vol.17
, Issue.3
, pp. 75-89
-
-
Mason, B.1
Kocsis, J.2
Melia, D.3
Khuri, E.4
Sweeney, J.5
Wells, A.6
Borg, L.7
Millman, R.8
Kreek, M.9
-
71
-
-
29744440510
-
The characteristics of heroin users entering treatment: Findings from the Australian treatment outcome study (ATOS)
-
Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev. 2005;24(5):411-8.
-
(2005)
Drug Alcohol Rev
, vol.24
, Issue.5
, pp. 411-418
-
-
Ross, J.1
Teesson, M.2
Darke, S.3
Lynskey, M.4
Ali, R.5
Ritter, A.6
Cooke, R.7
-
72
-
-
0033849125
-
Methadone dose and retention during treatment of heroin addicts with axis 1 psychiatric comorbidity
-
Maremmani I, Zolesi O, Agletti M, Tagliamonte A, Shinderman M, Maxwell S. Methadone dose and retention during treatment of heroin addicts with axis 1 psychiatric comorbidity. J Addic Dis. 2000;19(2):29-41.
-
(2000)
J Addic Dis
, vol.19
, Issue.2
, pp. 29-41
-
-
Maremmani, I.1
Zolesi, O.2
Agletti, M.3
Tagliamonte, A.4
Shinderman, M.5
Maxwell, S.6
-
73
-
-
33747005681
-
Predictors of retention in methadone programs: A signal detection analysis
-
Villafranca S, Mckellar J, Trafton J, Humphreys K. Predictors of retention in methadone programs: a signal detection analysis. Drug Alcohol Depend. 2006;83(3): 218-24.
-
(2006)
Drug Alcohol Depend
, vol.83
, Issue.3
, pp. 218-224
-
-
Villafranca, S.1
Mckellar, J.2
Trafton, J.3
Humphreys, K.4
-
74
-
-
0036470906
-
Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis
-
Farre M, Mas A, Torrens M, Moreno V, Cami J. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend. 2002;65(3):283-90.
-
(2002)
Drug Alcohol Depend
, vol.65
, Issue.3
, pp. 283-290
-
-
Farre, M.1
Mas, A.2
Torrens, M.3
Moreno, V.4
Cami, J.5
-
75
-
-
27544440794
-
Methadone dosage and retention: An examination of the 60 mg/day threshold
-
Brady T, Salvucci S, Sverdlov L, Male A, Kyeyune H, Sikali E, DeSale S, Yu P. Methadone dosage and retention: an examination of the 60 mg/day threshold. J Addict Dis. 2005;24(3):23-47.
-
(2005)
J Addict Dis
, vol.24
, Issue.3
, pp. 23-47
-
-
Brady, T.1
Salvucci, S.2
Sverdlov, L.3
Male, A.4
Kyeyune, H.5
Sikali, E.6
DeSale, S.7
Yu, P.8
-
76
-
-
0036398960
-
Optimizing long-term response to methadone maintenance treatment: A 152-week follow-up using higher-dose methadone
-
Maxwell S, Schinderman M. Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone. J Addict Dis. 2002;21(3):1-12.
-
(2002)
J Addict Dis
, vol.21
, Issue.3
, pp. 1-12
-
-
Maxwell, S.1
Schinderman, M.2
-
77
-
-
0029947958
-
Retention in a low-threshold methadone maintenance program
-
Torres M, Castillo C, Perez V. Retention in a low-threshold methadone maintenance program. Drug Alcohol Depend. 1996;41(1):55-9.
-
(1996)
Drug Alcohol Depend
, vol.41
, Issue.1
, pp. 55-59
-
-
Torres, M.1
Castillo, C.2
Perez, V.3
-
78
-
-
33645374063
-
Determining effective methadone doses for individual dependent patients
-
Trafton J, Minkel J, Humphreys K. Determining effective methadone doses for individual dependent patients. PLoS Med. 2006;3(3):80-94.
-
(2006)
PLoS Med
, vol.3
, Issue.3
, pp. 80-94
-
-
Trafton, J.1
Minkel, J.2
Humphreys, K.3
-
79
-
-
67650259724
-
-
Tenore P. CARF Review Data File, Oct 2000, Albert Einstein College of Medicine, Division of Substance Abuse, Division of Psychiatry, data on file.
-
Tenore P. CARF Review Data File, Oct 2000, Albert Einstein College of Medicine, Division of Substance Abuse, Division of Psychiatry, data on file.
-
-
-
-
80
-
-
30444441986
-
Methadone reduces need for psychiatric agents in heroin addicts hospitalized for panic and/or acute psychotic episodes
-
Matteo P, Maremanni I. Methadone reduces need for psychiatric agents in heroin addicts hospitalized for panic and/or acute psychotic episodes. Heroin Add & Rel Clin Probl. 2005;7(4):43-8.
-
(2005)
Heroin Add & Rel Clin Probl
, vol.7
, Issue.4
, pp. 43-48
-
-
Matteo, P.1
Maremanni, I.2
-
81
-
-
0035253517
-
The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients
-
Cacciola J, Alterman A, Rutherford M, McKay J, Mulvaney F. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend. 2001;61(3):271-80.
-
(2001)
Drug Alcohol Depend
, vol.61
, Issue.3
, pp. 271-280
-
-
Cacciola, J.1
Alterman, A.2
Rutherford, M.3
McKay, J.4
Mulvaney, F.5
-
82
-
-
0018953959
-
Personalilty type and dose levels in methadone maintenance
-
Treece C, Nicholson B. Personalilty type and dose levels in methadone maintenance. J Nerv Ment Dis. 1980;168(10):621-8.
-
(1980)
J Nerv Ment Dis
, vol.168
, Issue.10
, pp. 621-628
-
-
Treece, C.1
Nicholson, B.2
-
83
-
-
0036049929
-
Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: Characteristics and a pharmacotherapeutic approach
-
Bleich A, Gelkopf M, Weizman T, Adelson M. Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach. Isr J Psychiatry Relat Sci. 2002;39(2):104-12.
-
(2002)
Isr J Psychiatry Relat Sci
, vol.39
, Issue.2
, pp. 104-112
-
-
Bleich, A.1
Gelkopf, M.2
Weizman, T.3
Adelson, M.4
-
84
-
-
67650229267
-
-
Tenore P. CARF Review Data File, Oct 2006, Albert Einstein College of Medicine Division of Substance Abuse, Division of Psychiatry, data on file.
-
Tenore P. CARF Review Data File, Oct 2006, Albert Einstein College of Medicine Division of Substance Abuse, Division of Psychiatry, data on file.
-
-
-
-
85
-
-
0026463116
-
-
McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199-213.
-
McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9(3):199-213.
-
-
-
-
86
-
-
0028600558
-
-
Nunes E, Quitkin F, Brady R, Post-Koenig T. Antidepressant treatment in methadone maintenance patients. J Addict Dis. 1994;13(3):13-24.
-
Nunes E, Quitkin F, Brady R, Post-Koenig T. Antidepressant treatment in methadone maintenance patients. J Addict Dis. 1994;13(3):13-24.
-
-
-
-
88
-
-
0032501365
-
-
National Consensus Development Panel on Effective Treatment of Opiate Addiction
-
National Consensus Development Panel on Effective Treatment of Opiate Addiction. JAMA. 1998;280: 1936-43.
-
(1998)
JAMA
, vol.280
, pp. 1936-1943
-
-
|